Needham initiated coverage on Enovis Corp (NYSE:ENOV) with a Buy and a price target of $70, noting that the company can sustain above-market growth in its Reconstructive segment via market share gains and acquisitions, which is expected to be accretive to earnings. 

The analyst says that Enovis has significant room for gross, operating, and EBITDA margin improvement and views the stock as an attractive valuation.

ENOV's Reconstructive business is its growth engine, and management expects to sustain 10-15% growth driven primarily by market share gains. 

Management is targeting >50 bps of EBITDA margin improvement annually, and product mix shifts alone will drive 20-30 bps of gross margin improvement and 10 bps of EBITDA margin improvement annually, the analyst says.

The analyst expects that M&A to remain a part of the company's strategy and notes that it ended 1Q23 with $22M of cash and $285 million of debt with an estimated leverage ratio (debt/EBITDA) of 1.2x. 

Needham notes that Enovis can finance up to $650-700 million of M&A with debt before reaching its maximum allowed leverage ratio of 4.0x. It may target high-growth, high-margin businesses and expect future deals to be accretive to earnings.

Price Action: ENOV shares are up 1.94% at $61.02 on the last check Monday.